Literature DB >> 26385031

Trends and predictors of readmission after catheter ablation for atrial fibrillation, 2009-2013.

Peter A Noseworthy1, Suraj Kapa2, Lindsey R Haas3, Holly Van Houten3, Abhishek J Deshmuk2, Siva K Mulpuru2, Christopher J McLeod2, Samuel J Asirvatham2, Paul A Friedman2, Nilay D Shah4, Douglas L Packer2.   

Abstract

UNLABELLED: As the number of patients undergoing catheter ablation for atrial fibrillation (AF) increases, there is a growing focus on optimizing the quality and efficiency of. Readmission is often considered an indicator of both quality and efficiency of care delivery. We sought to estimate rates and identify predictors of readmission after catheter ablation. METHODS AND
RESULTS: Using a large, national administrative claims database, we identified all AF patients who underwent catheter ablation between January 2009 and December 2013 (10,705 ablation cases). We examined incident readmission and the primary diagnosis during the readmission episode of care. We used Cox proportional hazard models to identify associations between readmission and patient and institutional characteristics. A total of 1,433 (13.4%) ablation patients were readmitted within 90 days of ablation for any cause, and 573 (5.4%) were admitted with AF as the primary diagnosis. There was a decline in all-cause (from 15.6% to 12.8%; P = .04) and AF-related (6.4%-5.0 %; P = .03) 90-day readmission over the study period. In a multivariate model, earlier year of ablation and each of 9 chronic conditions (alone or in combination) were independently associated with risk of readmission.
CONCLUSIONS: Between 2009 and 2013, there was a reduction in 90-day readmission rates after AF ablation, suggesting improved periprocedural care of these patients. Identifying patients at high risk for readmission after catheter ablation for AF may offer an opportunity for early intervention and, ultimately, reduction in procedural morbidity and medical costs.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26385031     DOI: 10.1016/j.ahj.2015.05.018

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  12 in total

1.  Short-Term Costs and Hospitalization Rates in Patients With Adult Congenital Heart Disease After Pulmonic Valve Replacement.

Authors:  Deana Mikhalkova; Eric Novak; Ari Cedars
Journal:  Am J Cardiol       Date:  2016-08-22       Impact factor: 2.778

Review 2.  Risk factors of adverse health outcomes after hospital discharge modifiable by clinical pharmacist interventions: a review with a systematic approach.

Authors:  Benedict Morath; Tanja Mayer; Alexander Francesco Josef Send; Torsten Hoppe-Tichy; Walter Emil Haefeli; Hanna Marita Seidling
Journal:  Br J Clin Pharmacol       Date:  2017-06-14       Impact factor: 4.335

3.  Outcomes of catheter ablation versus antiarrhythmic therapy in patients with atrial fibrillation: a systematic review and meta-analysis.

Authors:  Radhika Deshpande; Yasser AlKhadra; Prashanth Singanallur; Albert Botchway; Mohamed Labedi
Journal:  J Interv Card Electrophysiol       Date:  2022-09-03       Impact factor: 1.759

4.  Machine Learning Approach to Predict Risk of 90-Day Hospital Readmissions in Patients With Atrial Fibrillation: Implications for Quality Improvement in Healthcare.

Authors:  Man Hung; Eric S Hon; Evelyn Lauren; Julie Xu; Gary Judd; Weicong Su
Journal:  Health Serv Res Manag Epidemiol       Date:  2020-09-29

5.  Generalizability of the CASTLE-AF trial: Catheter ablation for patients with atrial fibrillation and heart failure in routine practice.

Authors:  Peter A Noseworthy; Holly K Van Houten; Bernard J Gersh; Douglas L Packer; Paul A Friedman; Nilay D Shah; Shannon M Dunlay; Konstantinos C Siontis; Jonathan P Piccini; Xiaoxi Yao
Journal:  Heart Rhythm       Date:  2020-03-04       Impact factor: 6.343

6.  Differences in Healthcare Use Between Patients With Persistent and Paroxysmal Atrial Fibrillation Undergoing Catheter-Based Atrial Fibrillation Ablation: A Population-Based Cohort Study From Ontario, Canada.

Authors:  Andrew C T Ha; Harindra C Wijeysundera; Feng Qiu; Kayley Henning; Kamran Ahmad; Paul Angaran; David H Birnie; Eugene Crystal; Andrew H Ha; Jeff S Healey; Peter Leong-Sit; Bhavanesh Makanjee; Pablo B Nery; Damian P Redfearn; Allan C Skanes; Atul Verma
Journal:  J Am Heart Assoc       Date:  2020-12-31       Impact factor: 5.501

7.  Feeding Tubes and Health Care Service Utilization in Amyotrophic Lateral Sclerosis: Benefits and Limits to a Retrospective, Multicenter Study Using Big Data.

Authors:  Keith M Swetz; Stephanie M Peterson; Lindsey R Sangaralingham; Ryan T Hurt; Shannon M Dunlay; Nilay D Shah; Jon C Tilburt
Journal:  Inquiry       Date:  2017-01-01       Impact factor: 1.730

8.  A systematic review protocol for examining 30-day readmission costs for atrial fibrillation patients.

Authors:  Taylor-Jade Woods; Peter Speck; Billingsley Kaambwa
Journal:  BMJ Open       Date:  2019-10-10       Impact factor: 2.692

9.  California Study of Ablation for Atrial Fibrillation:Re-hospitalization for Cardiac Events (CAABL-CE).

Authors:  Uma N Srivatsa; Guibo Xing; Ezra Amsterdam; Nipavan Chiamvimonvat; Nayereh Pezeshkian; Dali Fan; Richard H White
Journal:  J Atr Fibrillation       Date:  2018-06-30

10.  Causes and Predictors of Readmission in Patients With Atrial Fibrillation Undergoing Catheter Ablation: A National Population-Based Cohort Study.

Authors:  Shilpkumar Arora; Sopan Lahewala; Byomesh Tripathi; Varshil Mehta; Varun Kumar; Divya Chandramohan; Alejandro Lemor; Mihir Dave; Nileshkumar Patel; Nilay V Patel; Ghanshyam Palamaner Subash Shantha; Juan Viles-Gonzalez; Abhishek Deshmukh
Journal:  J Am Heart Assoc       Date:  2018-06-15       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.